Many Dentists Still Giving Patients Addictive Opioid Painkillers

THURSDAY, Oct. 21, 2021 (HealthDay News) -- Though most U.S. dentists say non-opioid painkillers effectively manage dental pain, nearly half still prescribe potentially addictive opioid painkillers, a new survey reveals.
In all, 84% of the 269 respondents said NSAID-acetaminophen combos are as effective as opioids or even more so, but 43% also said they regularly prescribe opioid medications.
The findings were published Oct. 21 in the Journal of the American Dental Association.
"These results suggest that dentists are familiar with the evidence about the effectiveness of NSAID-acetaminophen medications, but their self-reported prescribing patterns demonstrate a disconnect," said first author Matthew Heron, who conducted the study as an undergraduate at Georgetown University's School of Nursing and Health Studies in Washington, D.C. He spoke in a Georgetown news release.
Previous studies have found that dentists represent 8.6% of opioid prescribers in the United States, and are the biggest prescribers of opioids to patients 18 and younger.
"We know that the first exposure to opioids for many people occurs in their teens and early 20s following common dental procedures like third molar extractions," said study co-author Nkechi Nwokorie, who also conducted the work as a Georgetown undergrad. "This is a particularly vulnerable population for misuse."
Dr. Adriane Fugh-Berman is director of PharmedOut, a Georgetown project that was involved in the study.
"This underscores the need for more education about the harms of opioids and the need for national guidelines to align clinical practice with current evidence," she said. Fugh-Berman is also a professor in the departments of pharmacology, physiology and family medicine at Georgetown University Medical Center.
More information
The U.S. National Institute on Drug Abuse has more about prescription opioids.
SOURCE: Georgetown University Medical Center, news release, Oct. 21, 2021
Related Posts
Merck Asks FDA to Approve First COVID Antiviral Pill
TUESDAY, Oct. 12, 2021 (HealthDay News) -- Merck & Co. announced Monday that...
Metachronous Pathology Assessed in Young-Onset CRC Survivors
TUESDAY, Sept. 27, 2022 (HealthDay News) -- The incidence rate of clinically...
Un medicamento para el cáncer podría salvar las vidas de los pacientes con COVID hospitalizados
MIÉRCOLES, 6 de julio de 2022 (HealthDay News) -- Un medicamento experimental...
Beber incluso un poco de café en el embarazo podría atrofiar el crecimiento de un niño
MARTES, 1 de noviembre de 2022 (HealthDay News) -- A la mayoría de las mujeres...
